Dexketoprofentrometamolloadedsolid lipid nanoparticles(SLNs): Formulation, in vitroand in vivoevaluation

Development, in vitroand in vivoevaluation of dexketoprofen trometamol (DT)-loaded nanosizeddrugdelivery system was aimed in this study. DT-loaded solid lipid nanoparticles (SLNs) were prepared using probe sonication. DT release from SLNs prepared and their kinetics were investigated. Structures of SLNs were elucidated by particle size and zeta potential measurements, shape and surface imaging, thermal analysis,X-ray diffraction, FT-IR and 1H-NMR determinations. DT-loaded particles demonstrated characteristic plaque shapes while in vitrorelease studies showed extended release of DT. Korsmeyer-Peppas kinetic model was found to fit the best using DDSolversoftware program. Stability, cytotoxicity and in vivoanimal experiments were further performed on DT-loaded SLN showing also prolonged analgesic activity in mice. Depending on the in vitroand in vivotest results, formulation developed in this study seems to prolong DT release and is promising for extending analgesic activity.

PDF

___

[1]SternkeEA,AbrahamsonK, BaiMJ.Comorbid chronicpain and depression: patient perspectives on empathy.Pain. Manag Nurs. 2016;17(6):1-9.[CrossRef]
[2]Öztürk AA, Yenilmez E, Yazan Y. Dexketoprofen trometamol-loaded Eudragit® RL 100 nanoparticle formulation, characterization and release kinetics. Acta Pharm Sci. 2018; 57(1): 69-84. [CrossRef]
[3]DugowsonCE, GnanashanmugamP.Nonsteroidal anti-inflammatory drugs. Phys Med Rehabil Clin N Am.2006;17: 347-354. [CrossRef]
[4]Öztürk AA, Yenilmez E, ŞenelB, Arslan R, Yazan Y. Dexketoprofen trometamol-loaded Kollidon®SR and Eudragit®RS 100 polymeric nanoparticles: formulation and in vitro-in vivo Evaluation. Lat Am J Pharm. 2017;36(11):2153-2165.
[5]MatsuiH, ShimokawaO, KanekoT, NaganoY, RaiK, HyodoI.The pathophysiology of nonsteroidal antiinflammatory drug (NSAID) induced mucosal injuries in stomach and small intestine.J Clin Biochem Nutr. 2011; 48(07):107-111. [CrossRef]
[6]CarabazaA, CabréF, RotllanE, GómezM, GutiérrezM, GarcíaML, MauleónD.Stereoselective inhibition of inducible cyclooxygenase by chiral nonsteroidal anti-inflammatory agents.J Clin Pharmacol. 1996; 36:505-512.[CrossRef]
[7] BurkeD, BannisterJ.Dexketoprofen trometamol in post-operative pain management.Acut Pain.2003;5:57-62.[CrossRef]
[8]MauleónD, ArtigasR, GarcíaML, CarganicoG.Preclinical and clinical development of dexketoprofen.Drugs.1996;5(24):24-46.[CrossRef]
[9]MainardiF, MaggioniF, PezzolaD, ZavaD, ZanchinG.Dexketoprofen trometamol in the acute treatment of migraine attack: a phase II, randomized, double-blind, crossover, blank controlled, dose optimization study.J Pain. 2014; 15(4): 388-394. [CrossRef]
[10]MüllerRH, MäderK, GohlaS.Solid lipid nanoparticles (SLN) for controlled drug delivery-a review of the state of the art.Eur J Pharm Biopharm. 2000; 50(1):161-177. [CrossRef]
[11]MehnertW, MäderK.Solid lipid nanoparticles-Production, characterization and applications.Adv Drug Deliv Rev. 2012; 64: 83-101.[CrossRef]
[12]GarudA, SinghD, GarudN.Solid lipid nanoparticles (SLN): method, characterization and applications.Int Curr Pharm J.2012; 1(11): 384-393.[CrossRef]
[13]Öztürk AA, Gündüz AB, Özışık O. Supervised machine learning algorithms for evaluation of solid lipid nanoparticles and particle size. Comb Chem High Thoughput Screen. 2018; 21(9): 693-699. [CrossRef]
[14]SantosHM, CapeloJL.Trends in ultrasonic-based equipment for analytical sample treatment.Talanta.2007;73:795-802.[CrossRef]
[15]Kaur I, Ellis LJ, Romer I, Tantra R, CarriereM, Allard S, Mayne-L'Hermite M, Minelli C, Unger W, Potthoff A, Rades S, Valsami-Jones E. Dispersion of nanomaterials in aqueous media: towards protocol optimization. J Vis Exp. 2017; 130: 56074. [CrossRef]
[16]AburahmaMH, Badr-EldinSM. Compritol 888 ATO: a multifunctional lipid excipient in drug delivery systems and nanopharmaceuticals.Expert OpinDrug Deliv.2014;11(12):1865-1883. [CrossRef]
[17]PandyaJB,ParmarRD, SoniwalaMM, ChavdaJR. Solid lipid nanoparticles: overview on excipients.AJPTI.2013;01(03):1-9.
[18]FrancoF, Pérez-MaquedaLA, Pérez-RodríguezJL.The effect of ultrasound on the particle size and structural disorder of a well-ordered kaolinite.J Colloid Interface Sci.2004;274:107-117.[CrossRef]
[19]LopedotaA, TrapaniA, CutrignelliA, ChiarantiniL, PantucciE, CurciR, ManualiE, TrapaniG.The use of Eudragit RS 100/cyclodextrin nanoparticles for the transmucosal administration of glutathione.Eur J Pharm Biopharm.2009;72:509-520. [CrossRef]
[20]NumanogluU, Tarımcı N., Characterization of solid lipid nanoparticles (SLNTM) and theı̇r pharmaceutical and cosmetic applications.J Fac PharmAnkara.2006;35(3):211-235.
[21]NagarwalRC, KantS, SinghPN, MaitiP, PanditJK.Polymeric nanoparticulate system: apotential approach for ocular drug delivery.J Control Release. 2009; 136: 2-13. [CrossRef]
[22]VenkateswarluV, ManjunathK. Preparation, characterization and in vitro release kinetics of clozapine solid lipid nanoparticles.J Control Release.2004;95:627-638. [CrossRef]
[23]BüyükköroğluG, YazanY, ÖnerAF.Preparation and physicochemical characterizations of solid lipid nanoparticles containing DOTAP for DNA delivery. Turk J Chem. 2015; 39: 1012-1024.
[24]BaşaranE, DemirelM, SırmagülB, YazanY.Cyclosporine-A incorporated cationic solid lipid nanoparticles for ocular delivery.J Microencapsul.2010;27(1):37-47. [CrossRef]
[25]JenningV, GohlaSH.Comparison of wax and glyceride solid lipid nanoparticles (SLN®).Int J Pharm. 2000; 196: 219-222. [CrossRef]
[26]Öztürk AA, Martin-Banderas L, Cayero Otero MD, Yenilmez E, Şenel B, Yazan Y. Dexketoprofen trometamol-loaded poly-lactic-co-glycolic acid (PLGA) nanoparticles: preparation, in vitro characterization and cyctotoxity. Trop J Pharm Res. 2019; 18(1): 1-11. [CrossRef]
[27]JenningV, MaderK, GohlaS.Solid lipid nanoparticles (SLNTM) based on binary mixtures of liquid and solid lipids: A 1H-NMR study.Int JPharm.2000;205: 15-21. [CrossRef]
[28]BucoloC, DragoF, SalomoneS.Ocular drug delivery: a clue from nanotechnology. Front Pharmacol. 2012; 130(2): 192-201.[CrossRef]
[29]Zhang Y, Huo M, Zhou J, Zou A, Li W, Yao C, Xie S. DDSolver: an add-in program for modeling and comparison of drug dissolution profiles. AAPS J. 2010; 12: 263-271.[CrossRef]
[30]DashS, MurthyPN, NathL, ChowdhuryP. Kinetic modeling on drug release from controlled drug delivery systems.Acta Pol Pharma.2010;67(3):217-223.
[31]ZuoJ, GaoY, Bou-ChacraN, LöbenbergR.Evaluation of the DDSolver software applications. BioMed Res Int.2014; Article ID 204925:1-9.[CrossRef]
[32]Kırımlıoğlu GY, Yazan Y, Erol K Ünel ÇÇ. Gamma-aminobutyric acid loaded halloysite nanotubes and in vitro-in vivo evaluation for brain delivery. Int J Pharm. 2015;495(2):816-826. [CrossRef]
[33]BaekJS, ChoCW.Comparison of solid lipid nanoparticles for encapsulating paclitaxel or docetaxel.J Pharm Invest. 2015; 45:625–631.[CrossRef]
[34]WangJY, WangY, MengX.Chitosan nanolayered cisplatin-loaded lipid nanoparticles for enhanced anticancer efficacy in cervical cancer.Nanoscale Res Lett. 2016; 11: 524-535[CrossRef]
[35]OlbrichC, BakowskyJ, LehCM, MüllerRH, KneueC., Cationic solid-lipid nanoparticles can efficiently bind and transfect plasmid DNA.J Control Release. 2001; 77: 345–355.[CrossRef]
[36]YuanH, MiaoJ, DuYZ, YouJ, HuFQ, ZengSU. Cellular uptake of solid lipid nanoparticles and cytotoxicity of encapsulated paclitaxel in A549 cancer cells. Int J Pharm. 2008; 348:137-145[CrossRef]
[37]SagirO, SunayFB, YildirimH, AksozE, OzaslanS, KorogluA, AydemirT,UlusaAE,KockarF.Evaluation of the effects of dexketoprofentrometamol on knee joint: an in vivo & in vitro study.IndianJ Med Res.2013; 138(6):912-918.
[38]ShahKA, DateAA, JoshiMD, PatravaleVD.Solid lipid nanoparticles (SLN) of tretinoin: potential in topical delivery. Int J Pharm.2007;345: 163-171. [CrossRef]
[39]SiddiquiA,AlayoubiA, El-MalahY, NazzalS.Modeling the effect of sonication parameters on size and dispersion temperature of solid lipid nanoparticles (SLNs) by response surface methodology (RSM). Pharm Dev Technol.2014;19(3):342-346. [CrossRef]
[40]ArchanaK, VikasP.Development and validation of reversed-phase high performance liquid chomatographic method for estimation of dexketoprofen trometamol in bulk and tablet dosage form. AJPCT. 2013; 4:395-400.
[41]ÖztürkAA, YenilmezE, YazanY.Development and validation of high performance liquid chomatography (HPLC) modified method for dexketoprofen trometamol.EIJST.2017;6(4):33-41.
[42]AshM, AshI.Handbook of Green Chemicals.Second.Ed. Synapse Info Resources, New York, 2004.
[43] MedicinesComplete, Glyceryl Behenate,https://www.medicinescomplete.com/mc/excipients/2012/1001938956.htm, 2017
[44]KhoshneviszadehR, BazzazBSF, HousaindokhtMR, Ebrahim-HabibiA, RajabiO.A comparisonof explanation methods of encapsulation efficacy of hydroquinone in a liposomal system.J Paramed Sci. 2016; 7(2):23-28.
[45]MosmannT.Rapid colorimetric assay for cellular growth and survival: application to proliferation and cytotoxicity tests. J Immunol Methods. 1983; 65: 55-63.[CrossRef]
[46]GencerS, CebeciA, Irmak-YaziciogluMB.Silencing of the MMP-3 Gene by siRNA Transfection in Gastric Cancer AGS Cells.J GastrointestinLiver Dis.2010; 20:19-26.
[47]ArslanR, BektasN, OzturkY.Antinociceptive activity of methanol extract of fruits of Capparis ovata in mice.J. Ethnopharmacol. 2010; 131: 28–32.[CrossRef]